We serve PZM21 CAS:1997387-43-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Product Description:
Product Name: PZM21 CAS NO: 1997387-43-5
Synonyms:
1-[(2S)-2-(Dimethylamino)-3-(4-hydroxyphenyl)propyl]-3-[(2S)-1-(thiophen-3-yl)propan-2-yl]urea;
1-[(2S)-2-(Dimethylamino)-3-(4-hydroxyphenyl)propyl]-3-[(2S)-1-(thiophen-3-yl)propan-2-yl]urea;
Chemical & Physical Properties:
Appearance: White to off-white solid powder
Assay :≥98.0%
Boiling Point: 583.8±50.0℃(Predicted)
Density: 1.169±0.06 g/cm3 (Predicted)
PKa: 10.06±0.15 (Predicted)
Water Solubility: 10 mM in DMSO
PZM21 is a potent and selective μ opioid receptor agonist with an EC50 of 1.8 nM. PZM21 is a selective μ receptor agonist (EC50 = 4.6 nM). PZM21 has been reported to exhibit bias for the Gi signaling pathway over arrestin-3. The compound exhibits 500-fold selectivity for μ over δ receptors and no detectable activity at κ or nociceptin receptors and a panel of 316 other GPCRs. PZM21 induces analgesia in a mouse hot plate assay, but not a tail-flick assay and exhibits no significant conditioned place preference response in in vivo assays. CNS penetrant.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
Contact us for information like PZM21
1997387-43-5 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,PZM21
1997387-43-5 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,PZM21
1997387-43-5 Use and application,PZM21
1997387-43-5 technical grade,usp/ep/jp grade.
Related Products:1,3-bis(5-carboxy-2,4-dimethylpyrrole-3-yl)propane manufacturer | 5-methyl-5-(2-methylsulfanyl-ethyl)-imidazolidine-2,4-dione supplier | carbonic acid,2-(2-prop-2-enoxyethoxy)ethanol producer.
